TCM

TCG Crossover Management Portfolio holdings

AUM $876M
This Quarter Return
+32.25%
1 Year Return
+23.66%
3 Year Return
+996.72%
5 Year Return
–
10 Year Return
–
AUM
$610M
AUM Growth
+$610M
Cap. Flow
-$40M
Cap. Flow %
-6.56%
Top 10 Hldgs %
80.69%
Holding
24
New
2
Increased
4
Reduced
1
Closed
2

Top Buys

1
ICVX
Icosavax, Inc. Common Stock
ICVX
$36.8M
2
COGT icon
Cogent Biosciences
COGT
$23.7M
3
JBIO
Jade Biosciences, Inc. Common Stock
JBIO
$19.2M
4
GERN icon
Geron
GERN
$18.7M
5
ANTX icon
AN2 Therapeutics
ANTX
$11M

Top Sells

1
ISEE
IVERIC bio, Inc. Common Stock
ISEE
$106M
2
CBAY
Cymabay Therapeutics
CBAY
$26.6M
3
VRDN icon
Viridian Therapeutics
VRDN
$16.9M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ISEE
1
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$96.3M 15.8%
2,448,829
-2,692,289
-52% -$106M
GERN icon
2
Geron
GERN
$893M
$75.7M 12.42%
23,589,779
+5,824,566
+33% +$18.7M
COGT icon
3
Cogent Biosciences
COGT
$1.69B
$66.7M 10.93%
5,631,042
+2,000,000
+55% +$23.7M
VECT
4
DELISTED
VectivBio Holding AG Ordinary Shares
VECT
$52.9M 8.68%
3,113,600
– –
JBIO
5
Jade Biosciences, Inc. Common Stock
JBIO
$258M
$37.8M 6.19%
2,201,274
+1,120,000
+104% +$19.2M
ICVX
6
DELISTED
Icosavax, Inc. Common Stock
ICVX
$36.8M 6.03%
+3,703,704
New +$36.8M
MDGL icon
7
Madrigal Pharmaceuticals
MDGL
$9.76B
$34.6M 5.68%
149,917
– –
TYRA icon
8
Tyra Biosciences
TYRA
$675M
$33.9M 5.56%
1,989,103
– –
KALV icon
9
KalVista Pharmaceuticals
KALV
$678M
$30.6M 5.01%
3,395,495
– –
VTYX icon
10
Ventyx Biosciences
VTYX
$171M
$26.8M 4.39%
815,724
– –
DYN icon
11
Dyne Therapeutics
DYN
$1.92B
$18.6M 3.04%
1,650,150
– –
KURA icon
12
Kura Oncology
KURA
$686M
$15.1M 2.47%
1,423,642
– –
GPCR icon
13
Structure Therapeutics
GPCR
$1.11B
$14.5M 2.39%
350,000
– –
IMVT icon
14
Immunovant
IMVT
$2.56B
$12.4M 2.04%
654,853
– –
SLN
15
Silence Therapeutics
SLN
$227M
$11.6M 1.9%
2,104,875
– –
ANTX icon
16
AN2 Therapeutics
ANTX
$30.1M
$11M 1.8%
+1,289,320
New +$11M
TRDA icon
17
Entrada Therapeutics
TRDA
$208M
$8.86M 1.45%
584,955
– –
MRUS icon
18
Merus
MRUS
$4.98B
$7.9M 1.3%
300,000
– –
CABA icon
19
Cabaletta Bio
CABA
$133M
$6.28M 1.03%
486,795
– –
ACRS icon
20
Aclaris Therapeutics
ACRS
$209M
$5.49M 0.9%
529,839
– –
CCCC icon
21
C4 Therapeutics
CCCC
$185M
$3.51M 0.58%
1,276,574
+26,574
+2% +$73.1K
ALPN
22
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
$2.6M 0.43%
253,069
– –
VRDN icon
23
Viridian Therapeutics
VRDN
$1.5B
– –
-663,610
Closed -$16.9M
CBAY
24
DELISTED
Cymabay Therapeutics
CBAY
– –
-3,048,257
Closed -$26.6M